Examkin

Question

Difficulty: HardDepressive Disorders

For each of the following patient scenarios involving depressive symptoms or related disorders, select the most appropriate targeted pharmacotherapy or management step.

  • An elderly male patient exhibits severe psychomotor retardation, active delusions of his internal organs rotting, and life-threatening dehydration due to a complete refusal to eat or drink.Perform urgent electroconvulsive therapy (ECT)
  • A young adult female seeks help for severe low mood and anhedonia. A review of her psychiatric history confirms a distinct past period of inflated self-esteem, hypersexuality, and going days without sleep.Initiate treatment with lurasidone
  • A middle-aged male with unipolar depression reports significant residual hypersomnia, cognitive sluggishness, and fatigue despite a partial mood response to eight weeks of maximum-dose sertraline.Augment current regimen with bupropion
  • A postmenopausal female patient is evaluated for low mood, anhedonia, and worthlessness. She also suffers from painful diabetic neuropathy and frequent episodes of stress urinary incontinence.Initiate treatment with duloxetine

Answer

Match the medically compromised patient with psychotic depression to urgent ECT; the patient with bipolar depression to lurasidone; the patient with residual fatigue on SSRIs to bupropion augmentation; and the patient with comorbid neuropathy and stress incontinence to duloxetine.
Each clinical presentation requires a highly specific targeted intervention based on comorbidities, symptom profile, and medical urgency. Psychotic depression with inanition requires immediate ECT. Bipolar depression requires an atypical antipsychotic approved for that phase (like lurasidone). Residual fatigue on an SSRI benefits from NDRI augmentation (bupropion). MDD with neuropathic pain and stress incontinence is optimally treated with a dual-acting SNRI like duloxetine.

Step-by-Step Solution

1
Evaluate the elderly male patient with delusions and dehydration.
Diagnosis is Major Depressive Disorder with psychotic features and life-threatening inanition.
Electroconvulsive therapy (ECT) is the gold standard and most rapid treatment for severe depression complicated by psychosis and acute medical compromise, bypassing the delayed onset of pharmacotherapy.
2
Evaluate the young adult female with severe low mood and a past history of hypersexuality/decreased sleep.
Diagnosis is Bipolar I Disorder, currently in a depressive episode.
Standard antidepressant monotherapy (like SSRIs) is contraindicated. Lurasidone is an FDA-approved first-line agent specifically indicated for bipolar depression.
3
Evaluate the middle-aged male with residual fatigue and hypersomnia despite SSRI therapy.
The patient has a partial response to sertraline but suffers from residual amotivational and fatigue symptoms.
Bupropion, an activating NDRI, is the ideal augmentation strategy to target fatigue, poor concentration, and hypersomnia without causing weight gain or sexual dysfunction.
4
Evaluate the postmenopausal female with low mood, neuropathy, and stress incontinence.
Diagnosis is Major Depressive Disorder with comorbid diabetic peripheral neuropathy and stress urinary incontinence.
Duloxetine, an SNRI, treats the core depressive symptoms while also being formally indicated for neuropathic pain and demonstrating off-label efficacy in reducing stress urinary incontinence via increased urethral sphincter tone.

Key Concept

Selecting the most appropriate pharmacological or procedural intervention for complex depressive disorders based on comorbidities, prior treatment response, and acute medical urgency.
Rate this question

Topics

Depressive Disorders

More questions from this topic